Morgan Stanley Maintains Equal-Weight on Merck & Co, Raises Price Target to $116
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has maintained an Equal-Weight rating on Merck & Co (NYSE:MRK) and raised the price target from $109 to $116.
August 04, 2023 | 11:30 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Merck & Co and raised the price target from $109 to $116, which could potentially lead to an increase in the stock's price.
The raised price target by Morgan Stanley indicates a positive outlook for Merck & Co. This could potentially lead to an increase in the stock's price as it suggests that the analyst believes the stock is undervalued at its current price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100